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Background
CCR5 is the major HIV co-receptor, and individuals
homozygous for a 32-bp deletion in CCR5 are resistant
to infection by CCR5-tropic HIV-1. Zinc finger nuclease
(ZFN) technology is a class of engineered DNA-binding
proteins facilitating targeted genome editing by binding
to a user-specific locus and causing a double-strand
break in the region of interest. As a result, the gene of
interest targeted by ZFN cleavage is disrupted. We
investigated the ability of a Ccr5 gene-specific ZFN to
establish SIV-resistant CD4+ T cells and hematopoietic
progenitor cells isolated from macaques.
Methods
Bone marrow and blood samples were obtained from
ten naïve uninfected rhesus macaques. Immunomagnetic
enrichments were performed to isolate hematopoietic
stem/progenitor cells and CD4+ T cells using magnetic-
beads. Purified cells were nucleofected with RNAs
encoding for a Ccr5-specific ZFNs.
Results
We successfully engineered CCR5-modified macaque CD4
+ T lymphocytes that were resistant to in vitro infection
with SIVmac239, SIVmac251, and CCR5-tropism SIVagm.
CD4+ T lymphocytes that incorporated RNAs encoding
for the Ccr5-specific set of ZFNs marked resistance to SIV
infection as showed by lack of p27 expression in culture
supernatants. Infection of non-modified CD4+ T lympho-
cytes led to significant p27 production from day 5 post-
infection with a pick at day 7 post-infection. We developed
and optimized the conditions for proper isolation, expan-
sion and in vitro differentiation of macaque hematopoietic
stem cells to be used for the generation of SIV-resistant
macaque hematopoietic stem cells using our ZFNs. We
successfully engineered CD34+ hematopoietic stem cells
using nucleofection of RNAs encoding for a Ccr5-specific
ZFNs.
Conclusion
We demonstrated the feasibility of using ZFN technology
to establish CD4+ and hematopoietic stem cells resistant
to SIV infection in macaque model. The generation of a
nonhuman primate model using this modern molecular-
based strategy might significantly help in the design of
new therapies to prevent viral infection in human.
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